Drug:
Reaction: WRONG TECHNIQUE IN PRODUCT USAGE PROCESS
20250101 - 20251231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 25129604 |
US |
79 | 2 |
Wrong technique in product usage process, Product administered at inappropriate site, Extra dose administered, Visual impairment, Dizziness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 102 | 25129812 |
US |
52 | 2 |
Device adhesion issue, Wrong technique in product usage process, |
||||
ESTRADIOL AND LEVONORGESTREL, |
||||
| 103 | 25129947 |
US |
86 | 1 |
Wrong technique in product usage process, Product use complaint, |
||||
DAROLUTAMIDE, |
||||
| 104 | 25130205 |
US |
||
Product use in unapproved indication, Wrong technique in product usage process, |
||||
POLYETHYLENE GLYCOL 3350, |
||||
| 105 | 25130355 |
US |
40 | 1 |
Wrong technique in product usage process, |
||||
BEMPEDOIC ACID AND EZETIMIBE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 106 | 25130488 |
US |
1 | |
Wrong technique in product usage process, Drug intolerance, |
||||
SACUBITRIL AND VALSARTAN, |
||||
| 107 | 25130512 |
BR |
68 | 2 |
Blood pressure increased, Blood pressure increased, Pain in extremity, Discomfort, Cardiovascular disorder, Pain, Anxiety, Fatigue, Malaise, Weight decreased, Paraesthesia, Hypoaesthesia, Drug ineffective, Therapeutic product effect incomplete, Wrong technique in product usage process, Inappropriate schedule of product administration, Product packaging quantity issue, Product packaging issue, |
||||
AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE, AMLODIPINE VALSARTAN AND HYDROCHLOROTHIAZIDE, LOSARTAN, |
||||
| 108 | 25130666 |
US |
2 | |
Full blood count decreased, Wrong technique in product usage process, Product dose omission issue, |
||||
NIRAPARIB, NIRAPARIB, |
||||
| 109 | 25130850 |
30 | 1 | |
Wrong technique in product usage process, Liver disorder, Therapy interrupted, |
||||
ENTECAVIR, |
||||
| 110 | 25130967 |
US |
1 | |
Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 111 | 25131022 |
US |
79 | 2 |
Injection site haemorrhage, Injury associated with device, Wrong technique in product usage process, |
||||
EVOLOCUMAB, |
||||
| 112 | 25131099 |
US |
69 | 2 |
Product adhesion issue, Wrong technique in product usage process, Product storage error, |
||||
ESTRADIOL, |
||||
| 113 | 25131122 |
US |
2 | |
Wrong technique in product usage process, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 114 | 25131134 |
US |
35 | 2 |
Underdose, Wrong technique in product usage process, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 115 | 25131161 |
US |
||
Wrong technique in product usage process, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 116 | 25131192 |
US |
63 | 1 |
Diabetes mellitus inadequate control, Pruritus, Diarrhoea, Toothache, Bipolar disorder, Nasal discomfort, Weight decreased, Somnolence, Arthritis, Lacrimation increased, Dry mouth, Intentional product use issue, Product dose omission issue, Rhinorrhoea, Influenza, Blood glucose decreased, Wrong technique in product usage process, Drug ineffective, Inability to afford medication, |
||||
DEUTETRABENAZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, MAGNESIUM, MELATONIN, |
||||
| 117 | 25131202 |
US |
37 | 2 |
Adverse drug reaction, Nervousness, Product use in unapproved indication, Underdose, Wrong technique in product usage process, |
||||
PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, |
||||
| 118 | 25131379 |
US |
64 | 2 |
Wrong technique in product usage process, Product administered at inappropriate site, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 119 | 25131389 |
US |
26 | |
Blood glucose abnormal, Wrong technique in product usage process, |
||||
INSULIN LISPRO, INSULIN LISPRO, INSULIN LISPRO, |
||||
| 120 | 25131678 |
US |
2 | |
Off label use, Wrong technique in product usage process, |
||||
RUXOLITINIB, |
||||
| 121 | 25131919 |
US |
60 | 1 |
Pancreatitis, Wrong technique in product usage process, Diarrhoea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 122 | 25121160 |
JP |
70 | 1 |
Foreign body in throat, Sensation of foreign body, Wrong technique in product usage process, |
||||
ORAL SEMAGLUTIDE, |
||||
| 123 | 25121267 |
US |
2 | |
Diverticulitis, Wrong technique in product usage process, |
||||
INSULIN DEGLUDEC, INSULIN DEGLUDEC, |
||||
| 124 | 25121302 |
US |
75 | |
Drug dose omission by device, Wrong technique in product usage process, Off label use, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 125 | 25121309 |
US |
78 | |
Cough, Drug dose omission by device, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 126 | 25121338 |
US |
2 | |
Injury associated with device, Wrong technique in product usage process, |
||||
ADALIMUMAB, |
||||
| 127 | 25121420 |
US |
79 | 2 |
Device difficult to use, Accidental exposure to product, Wrong technique in product usage process, Drug dose omission by device, Nasopharyngitis, |
||||
EVOLOCUMAB, |
||||
| 128 | 25121583 |
FR |
14 | 2 |
Oesophageal ulcer, Wrong technique in product usage process, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 129 | 25121907 |
US |
40 | 1 |
Musculoskeletal stiffness, Wrong technique in product usage process, |
||||
ADALIMUMAB, |
||||
| 130 | 25121995 |
US |
1 | |
Hallucination, Tremor, Delusion, Loss of personal independence in daily activities, Wheelchair user, Abnormal behaviour, Dysstasia, Gait disturbance, Wrong technique in product usage process, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, ENTACAPONE, VIBEGRON, GLIMEPIRIDE, EMPAGLIFLOZIN, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, METOPROLOL TARTRATE, METOPROLOL, TEMAZEPAM, TRAVOPROST, TRAVOPROST (ISOMER FREE), ERGOCALCIFEROL, BREXPIPRAZOLE, |
||||
| 131 | 25122108 |
BR |
44 | 1 |
Loss of consciousness, Syncope, Wrong technique in product usage process, Blood glucose increased, Malaise, Product administration interrupted, Product formulation issue, Anxiety, |
||||
LISDEXAMFETAMINE DIMESYLATE, LISDEXAMFETAMINE, LISDEXAMFETAMINE DIMESYLATE CAPSULES, |
||||
| 132 | 25122248 |
US |
||
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 133 | 25122387 |
US |
2 | |
Wrong technique in product usage process, Eye discharge, |
||||
OLOPATADINE HYDROCHLORIDE, OLOPATADINE HYDROCHLORIDE, |
||||
| 134 | 25122413 |
US |
||
Contusion, Wrong technique in product usage process, |
||||
EMICIZUMAB, |
||||
| 135 | 25122416 |
US |
50 | 2 |
Wrong technique in product usage process, |
||||
PEGFILGRASTIM, PEGFILGRASTIM, |
||||
| 136 | 25122547 |
US |
1 | |
Product outer packaging issue, Wrong technique in product usage process, |
||||
OLOPATADINE HYDROCHLORIDE, |
||||
| 137 | 25122747 |
US |
2 | |
Infection, Wrong technique in product usage process, |
||||
DENOSUMAB, |
||||
| 138 | 25122914 |
US |
2 | |
Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 139 | 25123029 |
US |
68 | |
Incorrect dose administered by device, Drug dose omission by device, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 140 | 25123061 |
US |
61 | |
Wrong technique in product usage process, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 141 | 25123079 |
US |
65 | |
Wrong technique in product usage process, Device deposit issue, No adverse event, Device issue, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 142 | 25123139 |
US |
||
Dementia, Confusional state, Somnolence, Drug ineffective, Wrong technique in product usage process, |
||||
VIBEGRON, VIBEGRON, MIRABEGRON, |
||||
| 143 | 25123311 |
US |
2 | |
Wrong technique in product usage process, Nasopharyngitis, Urinary tract infection, Upper respiratory tract infection, |
||||
AZELASTINE HYDROCHLORIDE, AZELASTINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, TIZANIDINE HYDROCHLORIDE, GABAPENTIN, IPRATROPIUM BROMIDE, TIOTROPIUM BROMIDE INHALATION SPRAY, METHOCARBAMOL, METHOCARBAMOL TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, EPINEPHRINE, ADRENALINUM, METHYLPREDNISOLONE, CETIRIZINE HYDROCHLORIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, OXCARBAZEPINE, |
||||
| 144 | 25123606 |
US |
7 | 2 |
Wrong technique in product usage process, Overdose, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 145 | 25123732 |
US |
47 | |
Drug dose omission by device, Product preparation error, Wrong technique in device usage process, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 146 | 25123895 |
US |
||
Wrong technique in product usage process, Device deposit issue, Drug dose omission by device, Extra dose administered, Drug ineffective, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 147 | 25124123 |
US |
2 | |
Accidental exposure to product, Wrong technique in product usage process, Needle issue, |
||||
SECUKINUMAB, |
||||
| 148 | 25124236 |
US |
76 | |
Asthma exercise induced, Drug dose omission by device, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 149 | 25124279 |
US |
1 | |
Wrong technique in product usage process, Product packaging quantity issue, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 150 | 25124429 |
US |
75 | 1 |
Wrong technique in product usage process, Product administered at inappropriate site, Wrong patient received product, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 151 | 25124597 |
US |
40 | 2 |
Wrong technique in product usage process, Device mechanical issue, Device malfunction, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE, |
||||
| 152 | 25124711 |
CN |
||
Cyanosis, Gait inability, Suffocation feeling, Wrong technique in device usage process, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 153 | 25124817 |
US |
2 | |
Product use complaint, Wrong technique in product usage process, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 154 | 25125062 |
US |
2 | |
Wrong technique in product usage process, |
||||
UMECLIDINIUM, |
||||
| 155 | 25125272 |
US |
2 | |
Adverse drug reaction, Wrong technique in product usage process, Intentional underdose, |
||||
LEVOCETIRIZINE DIHYDROCHLORIDE, |
||||
| 156 | 25125645 |
US |
1 | |
Wrong technique in product usage process, Device delivery system issue, |
||||
SOMATROPIN, SOMATROPIN, |
||||
| 157 | 25126077 |
US |
||
Asthma, Product dose omission issue, Wrong technique in product usage process, Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 158 | 25126088 |
US |
||
Drug ineffective, Wrong technique in product usage process, |
||||
VIBEGRON, |
||||
| 159 | 25126208 |
US |
||
Wrong technique in product usage process, |
||||
MOMETASONE FUROATE, |
||||
| 160 | 25115618 |
US |
90 | |
Drug dose omission by device, Wrong technique in product usage process, No adverse event, |
||||
LEVALBUTEROL TARTRATE, LEVALBUTEROL TARTRATE, |
||||
| 161 | 25115632 |
CA |
1 | |
Pneumonia, Asthenia, Device issue, Malaise, Back pain, Dizziness, Fibromyalgia, Nasopharyngitis, Incorrect dose administered, Mobility decreased, Neck pain, Headache, Wrong technique in product usage process, Pain, Swelling, Fall, Arthralgia, |
||||
DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, CELECOXIB, METHOTREXATE, METHOTREXATE SODIUM, PREGABALIN, RANITIDINE, NAPROXEN, NAPROXEN SODIUM, ETANERCEPT, ADALIMUMAB, SECUKINUMAB, SECUKINUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 162 | 25115770 |
US |
86 | 2 |
Skin ulcer, Off label use, Wrong technique in product usage process, |
||||
EMPAGLIFLOZIN, |
||||
| 163 | 25115815 |
US |
59 | 2 |
Wrong technique in product usage process, Underdose, Contusion, Device issue, Needle issue, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
| 164 | 25116324 |
US |
72 | 2 |
Accidental exposure to product, Device defective, Product dose omission issue, Ill-defined disorder, Device issue, Wrong technique in product usage process, Device malfunction, |
||||
TOCILIZUMAB, CETIRIZINE HYDROCHLORIDE, LEVOTHYROXINE, PREDNISONE, EVOLOCUMAB, |
||||
| 165 | 25116402 |
US |
||
Device delivery system issue, Wrong technique in product usage process, Drug hypersensitivity, Aphonia, Product dose omission issue, Malaise, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 166 | 25116446 |
US |
||
Wrong technique in product usage process, Drug dose omission by device, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 167 | 25116475 |
US |
2 | |
Illness, Device difficult to use, Drug dose omission by device, Wrong technique in product usage process, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, |
||||
| 168 | 25116507 |
US |
1 | |
Incorrect dose administered, Wrong technique in product usage process, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 169 | 25116646 |
US |
67 | |
Drug dose omission by device, Wrong technique in product usage process, Product use in unapproved indication, Device deposit issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 170 | 25116667 |
US |
66 | |
Drug dose omission by device, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 171 | 25116767 |
US |
62 | 2 |
Wrong technique in product usage process, Product administered at inappropriate site, Incorrect dose administered, Injection site pain, Injection site haemorrhage, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 172 | 25116790 |
US |
60 | 2 |
Chemotherapy, Decreased appetite, Steatorrhoea, Wrong technique in product usage process, Anal incontinence, |
||||
PANCRELIPASE, |
||||
| 173 | 25117221 |
US |
||
Wrong technique in product usage process, Facial asymmetry, Off label use, |
||||
| 174 | 25117273 |
US |
2 | |
Swollen tongue, Tongue discomfort, Wrong technique in product usage process, Wrong product administered, |
||||
| 175 | 25117307 |
US |
79 | 1 |
Wrong technique in product usage process, Device issue, Injection site papule, Injection site swelling, Injection site erythema, |
||||
ADALIMUMAB, EMPAGLIFLOZIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 176 | 25117432 |
DE |
||
Myalgia, Fluid retention, Asthenia, Hypotonia, Arrhythmia, Abdominal pain upper, Wrong technique in product usage process, Inappropriate schedule of product administration, |
||||
BEMPEDOIC ACID, BEMPEDOIC ACID, |
||||
| 177 | 25117451 |
US |
66 | |
Drug dose omission by device, Device deposit issue, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 178 | 25117490 |
US |
75 | 1 |
Device difficult to use, Wrong technique in product usage process, Migraine, Product communication issue, Drug dose omission by device, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, |
||||
| 179 | 25117865 |
US |
70 | |
Drug dose omission by device, Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 180 | 25117878 |
US |
||
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device delivery system issue, |
||||
ALBUTEROL SULFATE, |
||||
| 181 | 25117935 |
83 | 2 | |
Pruritus, Eye pruritus, Scratch, Formication, Product use in unapproved indication, Wrong technique in product usage process, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, |
||||
| 182 | 25117940 |
70 | 1 | |
Renal pain, Wrong technique in product usage process, |
||||
ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, ALLOPURINOL, LENALIDOMIDE, APIXABAN, ACYCLOVIR, PREGABALIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ROSUVASTATIN, PANTOPRAZOLE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, IRON, ERGOCALCIFEROL, VITAMIN C, |
||||
| 183 | 25118073 |
US |
||
Somnolence, Wrong technique in product usage process, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 184 | 25118096 |
US |
57 | |
Dyspnoea, Drug dose omission by device, Wrong technique in product usage process, Device malfunction, |
||||
ALBUTEROL SULFATE, |
||||
| 185 | 25118136 |
US |
||
Wrong technique in product usage process, Device issue, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 186 | 25118159 |
US |
62 | |
Wrong technique in product usage process, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 187 | 25118217 |
US |
54 | |
Wrong technique in product usage process, Circumstance or information capable of leading to device use error, No adverse event, |
||||
ALBUTEROL SULFATE, |
||||
| 188 | 25118396 |
US |
2 | |
Blindness transient, Vision blurred, Wrong technique in product usage process, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, EPINEPHRINE, ADRENALINUM, PREDNISONE, IRON SUCROSE, |
||||
| 189 | 25118659 |
US |
||
Frustration tolerance decreased, Drug ineffective, Tension headache, Wrong technique in product usage process, |
||||
ATOGEPANT, PROPRANOLOL HYDROCHLORIDE, RIMEGEPANT SULFATE, RIMEGEPANT SULFATE, |
||||
| 190 | 25118682 |
PH |
2 | |
Dialysis, Product use in unapproved indication, Wrong technique in product usage process, |
||||
TOLVAPTAN, TOLVAPTAN, TOLVAPTAN, LOSARTAN, |
||||
| 191 | 25118690 |
US |
68 | 2 |
Food allergy, Wrong technique in product usage process, White blood cell disorder, White blood cell count abnormal, |
||||
LEVOTHYROXINE, LIOTHYRONINE SODIUM, |
||||
| 192 | 25118716 |
US |
1 | |
No adverse event, Incorrect product administration duration, Wrong technique in product usage process, |
||||
BUDESONIDE, BUDESONIDE, |
||||
| 193 | 25118776 |
US |
1 | |
Wrong technique in product usage process, Product adhesion issue, |
||||
OXYCODONE, |
||||
| 194 | 25119527 |
US |
2 | |
Drug ineffective, Wrong technique in product usage process, |
||||
EPTINEZUMAB-JJMR, |
||||
| 195 | 25119746 |
US |
2 | |
Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 196 | 25119975 |
US |
2 | |
Wrong technique in product usage process, |
||||
ALBUTEROL SULFATE, |
||||
| 197 | 25120249 |
US |
52 | 1 |
Rectal fissure, Injection site pain, Wrong technique in product usage process, |
||||
ADALIMUMAB, |
||||
| 198 | 25120495 |
US |
||
Hypertension, Nausea, Wrong technique in product usage process, |
||||
ISTRADEFYLLINE, ISTRADEFYLLINE, |
||||
| 199 | 25120787 |
US |
||
Wrong technique in product usage process, Extrasystoles, Device delivery system issue, Feeling abnormal, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 200 | 25120819 |
US |
76 | 2 |
Injection site pain, Device difficult to use, Drug dose omission by device, Wrong technique in product usage process, |
||||
EVOLOCUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28